Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Polycystic Ovary Syndrome 21Insulin Resistance 5Obesity 4Neoplasms 3Prostatic Neoplasms 2Motor Activity 2Menstruation Disturbances 2Medulloblastoma 2Infertility 2Diabetes Mellitus 2Breast Neoplasms 2Weight Loss 1Vitamin D Deficiency 1Triple Negative Breast Neoplasms 1Toxemia 1Thyroid Neoplasms 1Premature Birth 1Pregnancy Complications 1Prediabetic State 1Pre-Eclampsia 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Non-DM Stage II High-risk Colorectal Cancer 1Neoplasm Metastasis 1Mouth Neoplasms 1Metabolic Syndrome 1Liver Neoplasms 1Infertility, Female 1Hyperinsulinism 1Hyperandrogenism 1

Interventions

Megestrol Acetate 3Liraglutide 2lime 1Metformin 1Melatonin 1Exercise 1Exenatide 1Diet, Fat-Restricted 1Diet, Carbohydrate-Restricted 1Caseins 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Weight Loss × Metformin × Clear all
NCT05952882 2023-10-23

Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and Infertility

Mỹ Đức Hospital

Phase 3 Unknown
188 enrolled
Other

Infertility, Female, Insulin Resistance, Obesity, Polycystic Ovary Syndrome, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡